Condition
Dystonia, Focal
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07168850Not ApplicableRecruiting
Focused Ultrasound Unilateral Pallidotomy for Medication-Refractory Limb Dystonia
NCT07309133Recruiting
Local Field Potentials in Dystonia
NCT03428009Recruiting
Dystonia Genotype-Phenotype Correlation
NCT05095493Not ApplicableCompletedPrimary
Oral Zinc Supplementation to Enhance Botulinum Neurotoxin Response
NCT04560101UnknownPrimary
Motor and Non-motor Symptoms in Cervical Dystonia
Showing all 5 trials